Cargando…

Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis

The incidence of prostate cancer (PCa) in men globally increases as the standard of living improves. Blood serum biomarker prostate‐specific antigen (PSA) detection is the gold standard assay that do not meet the requirements of early detection. Herein, a solution‐gated graphene transistor (SGGT) bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Minghua, Ren, Zhanpeng, Zhang, Huibin, Li, Ziqin, Xue, Chenglong, Wang, Jianying, Zhang, Dan, Yang, Huan, Wang, Xianbao, Li, Jinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896035/
https://www.ncbi.nlm.nih.gov/pubmed/36480308
http://dx.doi.org/10.1002/advs.202205886
_version_ 1784881978807418880
author Deng, Minghua
Ren, Zhanpeng
Zhang, Huibin
Li, Ziqin
Xue, Chenglong
Wang, Jianying
Zhang, Dan
Yang, Huan
Wang, Xianbao
Li, Jinhua
author_facet Deng, Minghua
Ren, Zhanpeng
Zhang, Huibin
Li, Ziqin
Xue, Chenglong
Wang, Jianying
Zhang, Dan
Yang, Huan
Wang, Xianbao
Li, Jinhua
author_sort Deng, Minghua
collection PubMed
description The incidence of prostate cancer (PCa) in men globally increases as the standard of living improves. Blood serum biomarker prostate‐specific antigen (PSA) detection is the gold standard assay that do not meet the requirements of early detection. Herein, a solution‐gated graphene transistor (SGGT) biosensor for the ultrasensitive and rapid quantification detection of the early prostate cancer‐relevant biomarker, miRNA‐21 is reported. The designed single‐stranded DNA (ssDNA) probes immobilized on the Au gate can hybridize effectively with the miRNA‐21 molecules targets and induce the Dirac voltage shifts of SGGT transfer curves. The limit of detection (LOD) of the sensor can reach 10(−20) M without amplification and any chemical or biological labeling. The detection linear range is from 10(−20) to 10(−12) M. The sensor can realize real‐time detection of the miRNA‐21 molecules in less than 5 min and can well distinguish one‐mismatched miRNA‐21 molecule. The blood serum samples from the patients without RNA extraction and amplification are measured. The results demonstrated that the biosensor can well distinguish the cancer patients from the control group and has higher sensitivity (100%) than PSA detection (58.3%). Contrastingly, it can be found that the PSA level is not directly related to PCa.
format Online
Article
Text
id pubmed-9896035
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98960352023-02-08 Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis Deng, Minghua Ren, Zhanpeng Zhang, Huibin Li, Ziqin Xue, Chenglong Wang, Jianying Zhang, Dan Yang, Huan Wang, Xianbao Li, Jinhua Adv Sci (Weinh) Research Articles The incidence of prostate cancer (PCa) in men globally increases as the standard of living improves. Blood serum biomarker prostate‐specific antigen (PSA) detection is the gold standard assay that do not meet the requirements of early detection. Herein, a solution‐gated graphene transistor (SGGT) biosensor for the ultrasensitive and rapid quantification detection of the early prostate cancer‐relevant biomarker, miRNA‐21 is reported. The designed single‐stranded DNA (ssDNA) probes immobilized on the Au gate can hybridize effectively with the miRNA‐21 molecules targets and induce the Dirac voltage shifts of SGGT transfer curves. The limit of detection (LOD) of the sensor can reach 10(−20) M without amplification and any chemical or biological labeling. The detection linear range is from 10(−20) to 10(−12) M. The sensor can realize real‐time detection of the miRNA‐21 molecules in less than 5 min and can well distinguish one‐mismatched miRNA‐21 molecule. The blood serum samples from the patients without RNA extraction and amplification are measured. The results demonstrated that the biosensor can well distinguish the cancer patients from the control group and has higher sensitivity (100%) than PSA detection (58.3%). Contrastingly, it can be found that the PSA level is not directly related to PCa. John Wiley and Sons Inc. 2022-12-08 /pmc/articles/PMC9896035/ /pubmed/36480308 http://dx.doi.org/10.1002/advs.202205886 Text en © 2022 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Deng, Minghua
Ren, Zhanpeng
Zhang, Huibin
Li, Ziqin
Xue, Chenglong
Wang, Jianying
Zhang, Dan
Yang, Huan
Wang, Xianbao
Li, Jinhua
Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis
title Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis
title_full Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis
title_fullStr Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis
title_full_unstemmed Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis
title_short Unamplified and Real‐Time Label‐Free miRNA‐21 Detection Using Solution‐Gated Graphene Transistors in Prostate Cancer Diagnosis
title_sort unamplified and real‐time label‐free mirna‐21 detection using solution‐gated graphene transistors in prostate cancer diagnosis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896035/
https://www.ncbi.nlm.nih.gov/pubmed/36480308
http://dx.doi.org/10.1002/advs.202205886
work_keys_str_mv AT dengminghua unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis
AT renzhanpeng unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis
AT zhanghuibin unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis
AT liziqin unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis
AT xuechenglong unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis
AT wangjianying unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis
AT zhangdan unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis
AT yanghuan unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis
AT wangxianbao unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis
AT lijinhua unamplifiedandrealtimelabelfreemirna21detectionusingsolutiongatedgraphenetransistorsinprostatecancerdiagnosis